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ABSTRACT
Objective: Environment tobacco smoke (ETS) exposure in the household is dangerous to infants and children. Nicotine residue inhaled in the 
respiratory tract metabolized into cotinine which has the possibility of causing inflammation which can result in asthma exacerbation. The impact 
created by the exposure of ETS on children suffering from asthma is the sole objective of this research work.
Methods: A cohort study was carried out among 114 asthma patients aged 12–18 years old at three hospitals from January 2016 to March 2017. Data 
were obtained using self-reported questionnaires and cotinine urine test. The data analysis was carried with the use of Cox proportional hazard model 
with 95% confidence interval (CI).
Results: The result of the research showed that 57% of the patients got the trigger (event). The respondents consisted of 61.5% of female, average age 
of 15 years, 50.8% of upper secondary education, 55.4% of body mass index (BMI) normal, and 63.1% low economic status persons. Median survival 
for the ETS-exposed group was in a 9th week, while the median survival for the ETS non-exposed group was >12 weeks. Multivariate exposure of ETS 
with asthma exacerbation was hazard ratio (HR), 2.17; 95% CI, 1.23–3.83, p=0.008 and gender HR, 1.72; 95% CI, 1.04–2.85, p=0.035.
Conclusion: ETS exposure in the household increases the risk of asthma exacerbation. Controlling the environment and education of children to avoid 
ETS exposure should be intensified.
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INTRODUCTION
Epidemiological studies show that smoking is a global health 
problem and it is seen as a risk factor for the emergence of various 
medical disorders, especially some non-communicable diseases [1]. 
Environment tobacco smoke (ETS) has to do with the pollution of the 
environment, most rooms, with tobacco smokes, and that is why it is 
usually referred to as second-hand smoke. It comes with devastating 
impacts such as cardiovascular death and respiratory diseases, 
infections, behavioral problems, low birth weight, sudden infant death 
syndrome, and cancer [2,3]. Groups that are particularly vulnerable 
to this secondhand smoke are children, so they are easily affected by 
asthma, pneumonia, sinusitis, and different allergies.
Globally, about 40% of children with respiratory problems got them 
from smoking parents, as a result of this, about 28% of children deaths 
were associated with ETS in 2004 [2]. People that smokes are at risk of 
developing diabetes mellitus as well as be at increased risk of cancer of 
the bladder [4,5]. Exposure to tobacco smoke can cause heart attacks, 
strokes, and even sudden death. It was found that smoking causes about 
85% of lung cancers in the United States [6]. Sympathetic overactivity 
may lead to cardiovascular disease development in smokers. Cigarette 
smoking also has an adverse effect on serum ferritin, and other 
hematologic parameters and serum ferritin have been discovered to be 
one of the most reliable indicators of iron status [7,8]. The cyclooxygenase 
(Cox) proportional hazard model shows a higher hazard ratio (HR) for 
smokers prognostic impact in patients with lung adenocarcinoma [9].
One of the major effects of ETS that can result in death is asthma. 
Asthma is a chronic inflammatory disease of the respiratory tract 
characterized by wheezing, coughing, and chest tightness due to 
respiratory tract blockages. Epidemiological study of asthma reveals 
that the prevalence of several countries ranged from 1% to 18% [10], 
while, nationally, in Indonesia, it showed 4.5% [11]. Asthma is caused 
by many factors which include gene, family history of allergy and 
asthma, viral respiratory infections, bacterial colonization, allergic 
sensitization, body weight, hypertension, and tobacco exposure. 
These are the main risk factors associated with childhood-onset 
asthma [12,13].
Leftover cigarette smoke on surfaces does not evaporate into the air; 
however, there is nicotine residue attached to the dust or stuff around 
us, such as clothes, carpets, walls, furniture, or chairs. Nicotine dust is 
not going to disappear in a short time, so it will be inhaled by others 
even though the smoker has left the place [14,15].
More than 5200 chemical components are found in cigarette smoke in 
the form of particles and steam [16]. These chemicals are dangerous 
and can cause damages to the respiratory tract, in such a way that 
they can block overall breathing work [17]. One of these chemicals is 
nicotine, and it has a secondary immunomodulatory effect of eosinophil 
function, by inhibiting the release of pro-inflammatory cytokines from 
macrophages [18,19].
ETS exposure in the household can increase the severity of asthma in 
children because while they are on the floor, they inhale dust of carpet, 
mildew, mite, and others which are equivalent to sucking four cigarettes 
a day. Over 90% of children spend their time indoors, and because of 
the ETS, indoor air pollution gives more harmful health effects than 
outdoor air pollution [20].
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ETS exposure in the household can be inhaled through breath into the 
alveoli and then spread into the blood circulation if not stopped. In the 
metabolism, there are CYP2A6 genes, which are genes encoding P450 2a6 
of cytochrome enzyme. This enzyme is responsible for 70%–90% of 
nicotine metabolism in blood to cotinine [21-24]. Therefore, ETS exposure 
can be assessed through cotinine measurement in urine, serum, or saliva.
Nicotine in cigarette smoke can trigger inflammation because it has a 
direct effect on neutrophils and macrophages through the activation 
of nicotinic acetylcholine receptors in nerve cells as well as non-nerve 
cells such as monocytes and endothelial [25]. Several studies have also 
shown an increase in neutrophil inflammation in the bronchi and an 
increased number of neutrophils will trigger an increase in eosinophils, 
which will secrete inflammatory mediators that play a significant role 
in triggering asthma. Decreased IgE serum, blood eosinophils, and 
fractional exhaled nitric oxide non-smoker’s and former smoker’s ages 
had higher thymic stromal lymphopoietin than those that never smoke. 
In addition, goblet cell numbers will increase and hypersecretion of 
mucus in the respiratory tract [26]. The presence of cotinine urine levels 
in smokers has a positive relationship to increased levels of PGE-M and 
LTE4. This plays a role in inflammation and carcinogenesis [27].
The novelty of this study is to assess the risk impact associated 
with exposing children living with asthma to ETS in the family. We 
hypothesize that asthmatic children who are exposed to ETS in the 
family will experience an asthma exacerbation faster than those who 
are not exposed to ETS in the family.
METHODS
Study design
A cohort study was carried out among 114 asthma patients from three 
hospitals - Center for Healthy Lung Community (BBKPM), Surakarta, 
Dr. Moewardi Hospital, Surakarta, and Lung Health Center (Balkesmas) 
Klaten, Central Java, Indonesia from January 2016 to March 2017 
with the inclusion of some criteria. The research was carried out on 
respondents between the ages of 12 and 18 years. Survival analysis was 
carried out for asthma exacerbation.
Research ethics
We conducted a written informed consent before the data collection. 
The research ethics were obtained from the Ethics Committee of the 
Faculty of Medicine, Universitas Sebelas Maret, Indonesia.
Data collection
The data of respondents related to demography, BMI, and history of 
environmental tobacco exposure in the household were based on self-
report gotten through interview and questionnaire at the beginning of the 
research. The history of cigarette use includes the presence of smokers at 
home and number of cigarettes per day (1 to 10, 11 to 19, 20 to 29, and 
>30/day). Data were evaluated at 12 weeks or 3 months through self-report 
or medical records from the hospital to obtain sensory time analysis data. 
Urine sampling was also done in early research on every subject. Urine 
samples were used to determine levels of cotinine with the use of Enzyme-
Linked Immunosorbent Assay method [28-31]. Urine cotinine analysis data 
were classified into two categories which are: <15 ng/mlalso known as non-
exposed and higher than 15 ng/ml also known as exposed [28].
Data analysis
Data on demography, BMI, cigarette use, and cotinine concentration 
were obtained with the use of frequency distribution and percentage. 
We used the Log-rank test to evaluate the difference in time-to-event 
endpoints between patient groups. Multivariate Cox Proportional 
Hazard Models were fitted using all the covariates, yielding HRs 95% 
confidence interval (CI) with SPSS software.
RESULTS
Based on medical records from three hospitals; Center for Healthy Lung 
Community (BBKPM), Surakarta, Dr. Moewardi Hospital, Surakarta, and 
Lung Health Center (Balkesmas) Klaten, Central Java, Indonesia from 
January 2016 to March 2017. The total number of asthma patients in 
the three health-care facilities was 4872 with the number of children 
with asthma recorded to be 726. There were 114 children who fulfilled 
the criteria, and they were used as samples. During the research period, 
it was found that the trigger status (event) was 57% and the sensor was 
43%. Survival time showed that 50% respondent suffered the trigger in 
the 10th week, while the ETS-exposed group was in the 9th week.
Baseline characteristics as a single predictor of asthma exacerbation are 
summarized in Table 1. Cohort survival time showed that most of the 
respondents who suffered events were 61.5% female, at the mean age 
of 15 years, 50.8% of upper secondary education, 55.4% of BMI normal, 
and income <$105 (63.1%). Cotinine test as ETS biomarker showed that 
a high concentration of cotinine suffered more events (75.4%).
Table 1: The baseline of sociodemographic characteristics, ETS 
exposure, and trigger in adults with asthma exacerbation
Variables Event Sensor p value*
n (%) n (%)
Age
12–15 30 (46.15) 32 (65.31) 0.067
16–18 35 (53.85) 17 (34.69)
Mean±SD 15±2.5
Gender
Female 40 (61.54) 20 (40.82) 0.065
Male 25 (38.46) 29 (59.18)
Education
Primary 32 (49.23) 33 (67.35) 0.056
Upper secondary 33 (50.77) 16 (32.65)
BMI
Normal 36 (55.38) 20 (40.82) 0.186
Abnormal 29 (44.62) 29 (59.18)
Income
<$ 105 41 (63.08) 24 (48.98) 0.124
>$ 105 24 (36.92) 25 (51.02)
Cotinine
>15 ng/ml 49 (75.38) 26 (53.06) 0.010
<15 ng/ml 16 (24.62) 23 (46.94)
*The log-rank test (Mantel Cox) was used for all other characteristics. BMI: 
Body mass index, ETS: Environment tobacco smoke, Cox: Cyclooxygenase
The result of multivariate analysis with Cox regression (Cox proportional 
hazard model) showed that some variables, cotinine concentration 
and demographic variable (gender) have significant correlation with 
asthma exacerbation (HR, 2.17; 95% CI, 1.23–3.83) and (HR, 1.72; 95% 
CI, 1.04–2.85) (Table 2).
Table 2: Results of the multivariate analysis for overall survival
Variable Level HR (95% CI) p value*
Gender (Female vs. Male) 1.721 (1.040–2.849) 0.035
Cotinine (>15 ng/ml 
and<15 ng/ml)
2.168 (1.226–3.832) 0.008
*The Cox regression (Cox Proportional Hazard Model). HR: Hazard ratio, CI: 
Confidence interval, Cox: Cyclooxygenase
DISCUSSION
Median survival for both ETS-exposed and non-exposed groups was 
10 weeks. It shows that patients with asthma exacerbation will suffer 
the trigger in the 10th week. Asthma patients with ETS-exposed will 
rapidly suffer the trigger in the 9th week, while patients with ETS non-
exposed were >12 weeks. The result has the similarity as the other 
research that finds an average rate of asthma trigger to be 14 weeks or 
3.5 months/year (Figs. 1 and 2) [32].
Hazard survival ETS with urinary cotinine concentration of biomarker 
and frequency on the trigger of asthma exacerbation was HR, 2.17; 
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95% CI, 1.226–3.832, p=0.008. The result of this research shows that 
ETS exposure measured with urine cotinine level in children suffering 
asthma has risk 2 of having asthma exacerbation more rapidly when 
compared to children with non-exposure of cigarette smoke. There 
is a research that has proved that mothers who smoke increase four-
fold response to histamine as well as high level of cotinine increase 
the risk of acute asthma exacerbation by 1.8-fold [33]. Children with 
ETS-exposed have the higher risk of having uncontrolled asthma with 
OR=3.20; 95% CI=1.40–6.90 [34].
Children who live in homes with smoking members have increased 
cotinine level when compared with those living in homes with no 
smokers. It shows that ETS exposure is associated with the increasing 
urinary cotinine and acute exacerbation asthma trigger as well as 
decreasing lung function of forced expiratory volume in 1 s and 
the ratio of forced vital capacity [35]. Around 87.9% of nontobacco 
consumers in the United States had detectable acquired serum cotinine 
levels. Nearly 40% of children aged 2 months to 2 years are living with 
at least one smoker, and perhaps, their condition is exacerbated by ETS 
exposure [36].
A series of epidemiological surveys provide strong evidence of the 
relationship between parental smoking and the prevalence of asthma 
in school-age children [37,38]. A recent study and meta-analysis of 76 
studies have assessed that the effects of pre- or post-natal second-hand 
smoke exposure are associated with a 21–85% increased risk of asthma 
incident [39]. The strongest effect of prenatal maternal smoking on 
asthma in children aged 2 years old has CI 95% OR = 1.85 (1.3–2.5). In 
adolescence and adults, exposure to passive smoke is also associated 
with the prevalence of asthma [25].
The increase of urinary cotinine concentration is affected by the 
number of smokers in a household, and the number of cigarettes 
smoked. The result showed that the existing home smokers have 
cotinine concentrations >15 ng/ml at most. Category of heavy smokers 
or higher number of cigarettes >20 cigarettes per day areas is shown in 
Tables 3 and 4.
Table 3: ETS status at home and cotinine concentration
ETS Household Cotinine
≥15 ng/ml <15 ng/ml
Home with smoker 50 (66.7) 7 (17.9)
Home without smoker 25 (33.3) 32 (82.1)
ETS: Environment tobacco smoke
Table 4: Number of cigarettes and cotinine concentration
Number of cigarette Cotinine
≥15 ng/ml <15 ng/ml
<4 6 (12) 3 (42.9)
5–9 11 (22) 1 (14.3)
10–19 16 (32) 1 (14.3)
20–29 17 (34) 2 (28.6)
The variability of each individual against the pattern of cotinine 
metabolism due to exposure to existing nicotine is quite different. 
Therefore, it is possible that there may be the existence of cotinine 
in a household where there is no smoke. This may be attributed to 
exposure of the inhabitant(s) to cigarette smoke outside the home and 
other metabolism factors such as genetic variation, race, sex, use of oral 
contraceptives or other estrogen-containing hormones, renal, and drug 
failure, including anticonvulsants and rifampin as well as from foods 
they ate [23,40].
The main physiological features of asthma exacerbation are airways 
constriction and airflow obstruction, which are reversible. It is 
produced as a result of the contraction of bronchial smooth muscle, 
edema, and hypersecretion of mucus. Various trigger factors can lead 
to exacerbations. Acute bronchoconstriction caused by allergens occurs 
as a result of the release of mediators from mast cells [41]. The nature 
of tobacco smoke as inhalants, which are inhaled and exposed directly 
to the airway, causes a risk factor that has a relationship with asthma 
exacerbation events in children [17,42].
Our study found that children who lived with smokers tend to have high 
levels of cotinine and were more likely to experience asthma attacks 
compared to children who lived in smoke-free homes. These results 
prove that cigarette smoke triggers inflammation in the respiratory 
tract which causes asthma attacks exacerbation. Several studies have 
shown that an increase in the neutrophils inherent the airways will 
lead to an increase in eosinophils, which will release inflammatory 
mediators that play a role when asthma attacks [26]. People exposed to 
cigarettes will find an increase in T lymphocytes, especially CD8+ and 
macrophages along the airway wall, increased neutrophils in airway 
secretions, and peripheral airway infiltration with mononuclear cells 
and macrophages [43].
We also found the female gender more prone to having an asthma 
exacerbation HR attack, 1.72; 95% CI, 1.04–2.85). During our study 
of 114 children, the respondents were mostly girls (61.5%) and 
men (38.5%). Prakruthi et al. conducted a study which proved that 
women were more prone to asthma than men, out of 90 children 
examined, 66.7% females had asthma while 33.3% men were 
affected [44].
Fig. 1: Survival curve for the asthma exacerbation for all groups
Fig. 2: Survival curve for the asthma exacerbation and cotinine 
environment tobacco smoke exposure
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Tobacco smoke exposure may happen in a home (including childhood 
exposure from parents, siblings, other family members or from the 
environment). The best recommendation for individuals who have 
children with asthma exacerbations is the drug reliever and controller; 
however, long-term use of this medication has side effects. Tamarindus 
indica L. plants have been studied, and this plant can improve 
respiratory and anti-asthmatic patterns [45]. Proper preventive efforts 
and educational controls should be employed to stop smoking. The 
efforts of public health agencies through their regulations aimed at 
banning smoking in homes have successfully reduced ETS exposure.
CONCLUSION
This research revealed that ETS exposure in the household increases 
the risk of asthma exacerbation. Since children with asthma should 
have good survival and quality of life, it is, therefore, necessary and 
expedient to control the environment and educates children to avoid 
ETS Exposure.
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